Work from the T1D Exchange Quality Improvement Collaborative in the Spotlight at the ADA’s 84th Scientific Sessions
Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes
Real-World Status of Autoantibody Screening and Teplizumab Administration Readiness among Centers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
Multiple Daily Injection (MDI) to Automated Insulin Delivery (AID) vs. Non-AID Insulin Pump for Newly Diagnosed People with Type 1 Diabetes Offers Improvement in Glycemic Control
Understanding Off-Label Use of GLP-1 (Glucagon-Like Peptide-1 Receptor) Agonists among Providers Participating in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
Engaging Data Teams in Electronic Medical Record Data Extraction for Diabetes Real-World Data and Improvement Projects
Type 1 Diabetes Care and Device Use in Older Adults—Transatlantic Comparison Based on T1DX-QI and DPV Registries
Changes in HbA1c with GLP-1 Use in People with Type 1 Diabetes—Data from the T1D Exchange QI Initiative
Examining New-Onset Type 1 Diabetes Educational Practices among Centers in the T1D Exchange Quality Improvement Collaborative (T1DX-QI
Dynamics of Treatment Regimens and Glycemic Outcomes in >100,000 Children from International Pediatric Diabetes Registries
Diabetes Technology Education Processes among Centers in the T1D Exchange Quality Improvement Collaborative (T1DX-QI)
Reducing Inequity in the Use of Automated Insulin Delivery Systems by Adults With Type 1 Diabetes: Key Learnings From a Safety Net Diabetes Clinic Program
Type 1 Diabetes Glycemic Outcomes Are Improving: Real World Data of Over 80,000 People in the T1D Exchange Quality Improvement Collaborative
The latest T1D content
Research that matters
Our daily questions
Continue with Google
Continue with Facebook
